There are 3161 resources available
783P - ESCAT gene actionability detection in early-stage ovarian: A descriptive analysis of an Italian referral center
Presenter: Floriana Camarda
Session: Poster session 02
784P - Prognostic nomograms for gestational and non-gestational choriocarcinoma: A population-based study
Presenter: Mustafa Alshwayyat
Session: Poster session 02
785P - Online prognostic calculator for gestational trophoblastic neoplasia (GTN): A tool for personalized treatment planning
Presenter: Zena Haddadin
Session: Poster session 02
786P - Exploring risk factors for recurrence in stage I uterine leiomyosarcomas: Is there a subgroup with a favorable prognosis?
Presenter: Alejandro Gallego
Session: Poster session 02
787P - First-in-human, phase I study of CBP-1008, a first-in-class bi-specific ligand drug conjugate (Bi-XDC), in patients with advanced solid tumors
Presenter: Ning Li
Session: Poster session 02
788P - Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/ APGOT-OV3)
Presenter: Natalie Ngoi
Session: Poster session 02
789P - Translational study and preliminary clinical trial of WX390 monotherapy in cancers with concurrence of PIK3CA and ARID1A mutations
Presenter: Jiajia Li
Session: Poster session 02
790P - The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynecologic tumors (GTs)
Presenter: Carmen Garcia Duran
Session: Poster session 02
791P - Activity of ERK1/2 inhibitor ASTX029 in patients with gynecological malignancies harboring genomic alterations in the MAPK pathway
Presenter: Geoffrey Shapiro
Session: Poster session 02
792P - The differences in immunogenicity of TP53 mutated endometrial-, high-grade serous ovarian- and triple negative breast carcinomas
Presenter: Alain Zeimet
Session: Poster session 02